# ANIMMA 2021

21-25 June 2021
Clarion Congress Hotel Prague
Europe/Prague timezone
The ANIMMA 2021 Registration is OPEN!

## Multi-Feature Treatment Verification in Particle Therapy

Not scheduled
20m
3rd floor (Clarion Congress Hotel Prague)

### 3rd floor

#### Clarion Congress Hotel Prague

Freyova 945/33, 190 00 Prague 9 - Vysočany
Oral presentation 09 Environmental and Medical Sciences

### Speaker

Dr KÖGLER, Toni (OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany)

### Description

Particle therapy constitutes a promising and rapidly developing method in modern cancer treatment. In order to exploit its full potential, however, it requires detailed dose verification.
Although the applicability of in-beam positron emission tomography and prompt gamma rays has already been demonstrated in patients, range verification is not yet part of the clinical routine in particle therapy. This is due to not only the methodological limitations of previous systems, but also to commercial, clinical and physical boundary conditions.
In pencil beam scanning, the state-of-the-art treatment method in particle therapy, the number of secondary particles (essentially positrons, prompt gamma rays and fast neutrons) available per spot ($\Delta t = 10$ ms to $100$ ms) is limited. This leads to statistical accuracy limits for verification systems exploiting these secondary particles as range probes. The development of a clinically useable treatment verification system requires gathering as much information about the local dose, as possible.
The instantaneous fluence rate of prompt gamma rays reaching $5\times10^{6}$ cm$^{-2}$s$^{-1}$ to $10^{8}$ cm$^{-2}$s$^{-1}$ challenges modern data acquisitions connected to monolithic inorganic scintillators with typical sizes used in present verification systems. In order to reduce the detector load, and also with regard to the ever higher intensities of next generation medical accelerators, future systems have to be more granular.
Multi-Feature Treatment Verification combines and extends established methods (prompt gamma-ray imaging, spectroscopy, timing, etc.) in order to achieve higher reliability and performance. This idea was taken up by the NOVO project and expanded by a multi-particle approach. The NOVO (i.e. Neutron and gamma-ray imaging with quasi-monolithic organic detector arrays – a novel, holistic approach to real-time range assessment-based treatment verification in particle therapy) consortium is a large collaboration of medical, nuclear and detector physicists, nuclear engineers, and mathematicians, which aim to develop a holistic real-time treatment verification system in particle therapy.
Elements of a potential multi-feature/multi-particle treatment verification multi-channel system were characterized in a double time-of-flight experiment at the pulsed photo-neutron source nELBE (neutrons @ Electron Linac for beams with high Brilliance and low Emittance). The essential properties (time resolution, light yield, detection efficiency and pulse shape discrimination) of an EJ-276 plastic scintillator were determined.
The very first experimental results show that the time resolution ($\Delta T< 400$ ns) of a $20\times20\times200$ mm$^{3}$ EJ-276 plastic scintillator with double-sided readout will reach the high demands of such a proposed range verification system. However, the determined quality of the pulse-shape discrimination, the energy resolution and the quite high neutron detection threshold of above $200$ keV show that the light yield of this type of scintillator is not high enough to be used in a multi-feature-based treatment verification system. Particle transport calculations with MCNP6 and GEANT4 were performed to confirm the experimental results of a single detector element. Furthermore, they also show a promising measurement accuracy of a multi-channel overall system.

### Primary author

Dr KÖGLER, Toni (OncoRay – National Center for Radiation Research in Oncology, Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Helmholtz-Zentrum Dresden - Rossendorf, Dresden, Germany)